Weight loss, appetite suppression, and metabolic effects continue normally regardless of discomfort
On the other hand, tirzepatide is currently undergoing a phase-3 trial called SURPASS-CVOT to assess its potential cardiovascular benefits in T2D patients
Safety Concerns Healthcare professionals have raised concerns about the safety of compounded semaglutide, particularly regarding the use of salt forms of semaglutide
Diabetes Technology and CGM Continuous Glucose Monitoring ADA 2026 Broad CGM Mandate CGM is now recommended at diabetes onset for anyone on insulin, on agents that can cause hypoglycemia, or where CGM aids management
Research questions Researchers may use Melanotan 1 when designing comparisons around melanocortin signaling, pigment-cell biology, receptor selectivity, and photobiology models
Retatrutide: The New Weight Loss Drug Explained Retatrutide: The New Weight Loss Drug Explained A new experimental weight loss drug just posted trial results that beat everything before it so why isn't everyone talking about the catch